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Intelligence is highly heritable1 and a major determinant of human health and well-being2. 
Recent genome-wide meta-analyses have identified 24 genomic loci linked to variation in 
intelligence3-7, but much about its genetic underpinnings remains to be discovered. Here, we 
present the largest genetic association study of intelligence to date (N=269,867), identifying 
205 associated genomic loci (190 novel) and 1,016 genes (939 novel) via positional mapping, 
expression quantitative trait locus (eQTL) mapping, chromatin interaction mapping, and 
gene-based association analysis. We find enrichment of genetic effects in conserved and 
coding regions and associations with 146 nonsynonymous exonic variants. Associated genes 
are strongly expressed in the brain, specifically in striatal medium spiny neurons and 
hippocampal pyramidal neurons. Gene-set analyses implicate pathways related to nervous 
system development and synaptic structure. We confirm previous strong genetic correlations 
with multiple health-related outcomes, and Mendelian randomization results suggest 
protective effects of intelligence for Alzheimer’s disease and ADHD, and bidirectional 
causation with pleiotropic effects for schizophrenia. These results are a major step forward 
in understanding the neurobiology of cognitive function as well as genetically related 
neurological and psychiatric disorders.   
 
We performed a genome-wide association (GWAS) meta-analysis of 14 independent 
epidemiological cohorts of European ancestry and 9,295,118 genetic variants passing quality 
control (Table 1; Supplementary Table 1; Supplementary Figure 1). A flowchart of the study 
methodology is presented in Supplementary Figure 2 and additional details of the methods 
and results are presented in the Supplementary Note.  
 
GWAS META-ANALYSIS OF INTELLIGENCE   5 
Intelligence was assessed using various neurocognitive tests, primarily gauging fluid 
domains of cognitive functioning (Supplementary Information 1.1-1.2). Despite variation in 
form and content, cognitive test scores display a positive manifold of correlations, a robust 
empirical phenomenon that is observed in multiple populations8. Statistically, the variance 
common across cognitive tasks can be modeled as a latent factor denoted as g (the general 
factor of intelligence)9,10. In addition, twin- and family studies show strong genetic 
correlations across diverse cognitive domains11, suggesting pleiotropy, and across levels of 
ability11, substantiating the view of general intelligence as an aetiological continuum (with 
rare syndromic forms of severe intellectual disability being the exception12). Additionally, g-
factors extracted from different sets of cognitive tests correlate very strongly (>.9813,14), 
supporting the universality of g15,16. In meta-analyzing cognitive scores obtained using a 
variety of tests, we aim to boost the statistical power to detect genetic variants underlying 
g, which are likely to have pleiotropic effects across multiple domains of cognitive 
functioning. 
 
Despite sample and methodological variations, genetic correlations (rg) between cohorts 
were considerable (mean=0.67), and there was no evidence of heterogeneity between 
cohorts in the single nucleotide polymorphism (SNP) associations (Supplementary Table 2; 
Supplementary Results 2.1). Age-stratified meta-analyses indicated high genetic correlations 
(rg>0.62), and comparable heritability across age, as captured by the SNPs included in the 
analysis (h2SNP=0.19-0.22) (Supplementary Table 3; Supplementary Results 2.2). The full 
sample h2SNP was 0.19 (SE=0.01), in line with previous findings4,5, and an LD score intercept17 
of 1.08 (SE=0.02) indicated that most of the inflation (λGC=1.92) could be explained by 
polygenic signal6 (Supplementary Table 4; Supplementary Figure 3). 
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In the meta-analysis, 12,110 variants indexed by 242 lead SNPs in approximate linkage 
equilibrium (r2<0.1) reached genome-wide significance (GWS; P<5×10-8) (Figure 1a; 
Supplementary Tables 5-7; Supplementary Figures 4-5). These were located in 205 distinct 
genomic loci (Supplementary Results 2.3.1). We tested for replication using the proxy 
phenotype of educational attainment, which is correlated phenotypically (r=~0.40)18 and 
genetically (r=~0.70)19 with intelligence. We confirmed this high genetic correlation (rg=0.73) 
and observed sign concordance with educational attainment for 93% of GWS SNPs (P<1×10-
300), with replication for 48 loci (Supplementary Results 2.3.2; Supplementary Table 8). Using 
polygenic score prediction20,21, the current results explain up to 5.2% of the variance in 
intelligence in four independent samples (Supplementary Table 9, Supplementary Results 
2.3.3).  
 
We observed enrichment for heritability of SNPs in conserved regions (P=2.01×10-12), coding 
regions (P=1.67×10-6), and H3K9ac histone regions/peaks (P<6.26×10-5), and among common 
(minor allele frequency > 0.3) variants (Figure 1b; Supplementary Results 2.3.4; 
Supplementary Table 10; Supplementary Figures 6-7). Conserved and regulatory regions 
have previously been implicated in cognitive functioning22 but coding regions have not.  
 
Functional annotation of all candidate SNPs in the associated loci (SNPs with an r2≧0.6 with 
one of the independent significant SNPs, a suggestive P-value (P<1×10-5) and a MAF>0.0001; 
n=21,368) showed that these were mostly intronic/intergenic (Supplementary Table 6; 
Figure 1), yet 146 (81 GWS) SNPs were exonic non-synonymous (ExNS) (Supplementary Table 
11, Supplementary Results 2.3.5). Convergent evidence of strong association (Z=9.49) and 
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the highest observed probability of a deleterious protein effect (CADD23 score=34) was found 
for rs13107325. This missense mutation (MAF=0.065, P=2.23×10-21) in SLC39A8 was the lead 
SNP in locus 71 and the ancestral allele C was associated with higher scores on intelligence 
measures. The effect sizes for ExNS were individually small, with each effect allele accounting 
for a difference of 0.01 to 0.08 standard deviations. Supplementary Tables 6 and 11 and 
Supplementary Results 2.3.5 present a detailed catalog of variants in the associated genomic 
loci.  
 
To link the associated variants to genes, we applied three gene-mapping strategies 
implemented in FUMA24. Positional gene-mapping aligned SNPs to 522 genes by genomic 
location, eQTL (expression quantitative trait loci) gene-mapping matched cis-eQTL SNPs to 
684 genes whose expression levels they influence, and chromatin interaction mapping 
annotated SNPs to 227 genes based on three-dimensional DNA-DNA interactions (Figure 2; 
Supplementary Results 2.3.6; Supplementary Figures 8-9; Supplementary Tables 12-14). 
This resulted in 859 unique mapped genes, 435 of which were implicated by at least two 
mapping strategies and 139 by all three (Figure 3). Although not all of these genes are certain 
to have a role in intelligence, they point to potential functional links for the GWAS associated 
variants and give higher credibility to genes with convergent evidence of association from 
multiple sources. The FUMA-mapped genes were enriched for brain tissue expression and 
several regulatory biological gene-sets (Supplementary Results 2.3.6). Fifteen genes are 
particularly notable as they are implicated via chromatin interactions between two 
independent genomic risk loci (Figure 2; Supplementary Results 2.3.6). Cross-locus 
interactions implicated ELAVL2, PTCH1, ATF4, FBXL17, and MAN2A1 in left ventricle of the 
heart tissue, SATB2 in liver tissue, and MEF2C in 5 tissues. Multiple interactions in multiple 
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tissue types were seen for a cluster of 8 genes on chromosome 6 encoding zinc finger proteins 
and histones.  
 
We performed genome-wide gene-based association analysis (GWGAS) using MAGMA25 to 
estimate aggregate associations based on all SNPs in a gene (whereas FUMA annotates 
individually significant SNPs to genes). GWGAS identified 507 associated genes (Figure 3a; 
Supplementary Results 2.4.1; Supplementary Table 15), of which 350 were also mapped by 
FUMA (Figure 3b). In total, 105 genes were implicated by all four strategies (Supplementary 
Table 16). 
 
In gene-set analysis, six Gene Ontology26 gene-sets were significantly associated with 
intelligence: neurogenesis (P=4.78×10-7), neuron differentiation (P=4.82×10-6), central 
nervous system neuron differentiation (P=3.31×10-6), regulation of nervous system 
development (P=9.30×10-7), positive regulation of nervous system development (P=1.00×10-
6), and regulation of synapse structure or activity (P=5.42×10-6) (Supplementary Results 2.4.2; 
Supplementary Tables 17-18). Conditional analysis indicated that there were three 
independent associations, regulation of nervous system development, central nervous system 
neuron differentiation, and regulation of synapse structure or activity, which together 
accounted for the associations of the other sets. 
 
Linking gene-based P-values to tissue-specific gene-sets, we observed strong associations 
with gene expression across multiple brain areas (Figure 3c; Supplementary Results 2.4.2; 
Supplementary Table 19), particularly the frontal cortex (P=3.10×10-9). In brain single-cell 
expression gene-set analyses, we found significant associations of striatal medium spiny 
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neurons (P=2.02×10-14) and pyramidal neurons in the CA1 hippocampal (P=5.67×10-11) and 
cortical somatosensory regions (P=2.72×10-9) (Figure 3d; Supplementary Results 2.4.2; 
Supplementary Table 20). Conditional analysis showed that the independent association 
signal in brain cells was driven by medium spiny neurons, neuroblasts, and pyramidal CA1 
neurons. 
 
Intelligence has been associated with a wide variety of human behaviors15 and brain 
anatomy27. Confirming previous reports5,6, we observed negative genetic correlations with 
ADHD (rg=−0.36, P=4.58×10-23), depressive symptoms (rg=−0.27, P=6.20×10-10), Alzheimer’s 
disease (rg=−0.27, P=2.03×10-5), and schizophrenia (rg=−0.21, P=3.82×10-17), and positive 
correlations with longevity (rg=0.43, P=7.96×10-8) and autism (rg=0.25, P=3.14×10-7), among 
others (Supplementary Table 21; Supplementary Figure 10). Comparison with previous 
GWAS28 supported these correlations, showing numerous shared genetic variants across 
phenotypes (Supplementary Results 2.5; Supplementary Tables 22-23). Low enrichment (87 
of 1,518 genes, P=0.05) was found for genes previously linked to intellectual disability or 
developmental delay, indicating largely distinct biological processes. However, our results 
extend previous genetic research on normal variation in general intelligence, as catalogued 
in Supplementary Tables 24-25. 
 
We used Generalized Summary-statistic-based Mendelian Randomization29 to test for 
potential credible causal associations between intelligence and genetically correlated traits 
(Supplementary Results 2.5.3; Supplementary Figures 11-12; Supplementary Table 26). We 
observed a strong bidirectional effect of cognitive ability on educational attainment 
(bxy=0.549, P<1×10-320) and of educational attainment on intelligence (byx=0.480, P=6.85×10-
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82). Such findings are consistent with previous studies implicating bidirectional causal 
effects30,31. There was also a bidirectional association showing a strong protective effect of 
intelligence on schizophrenia (OR=0.50, bxy=−0.685, P=2.02×10-57) and a relatively smaller 
reverse effect (byx= −0.214, P=4.19×10-52), with additional evidence for pleiotropy 
(Supplementary Results 2.5.3). A number of previous reports support both a causal link and 
genetic overlap between these phenotypes32,33. Our results also suggested that higher 
intelligence had a protective effect on ADHD (OR=0.48, bxy=−0.734, P=2.57×10-46) and 
Alzheimer’s disease (OR=0.65, bxy=−0.435, P=3.59×10-14), but was associated with higher risk 
of autism (OR=1.38, bxy=0.321, P=1.12×10-3).  
 
In the present study, we have affirmed and expanded existing knowledge of the genetics of 
general intelligence, identifying 190 novel loci and 939 novel associated genes and replicating 
previous associations with 15 loci and 77 genes. The combined strategies of functional 
annotation and gene-mapping using biological data resources provide extensive information 
on the likely consequences of relevant genetic variants and put forward a rich set of plausible 
gene targets and biological mechanisms for functional follow-up. Gene-set analyses 
contribute novel insight into underlying neurobiological pathways, confirming the importance 
of brain-expressed genes and neurodevelopmental processes in fluid domains of intelligence 
and pointing towards the involvement of specific cell types. Our results indicate overlap in 
the genetic processes involved in both cognitive functioning and neurological and psychiatric 
traits and provide suggestive evidence of causal associations that may drive these 
correlations. These results are important for understanding the biological underpinnings of 
cognitive functioning and contribute to our understanding of related neurological and 
psychiatric disorders.  
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MSigDB curated gene-set database: 
http://software.broadinstitute.org/gsea/msigdb/collections.jsp 
 
NHGRI GWAS catalog: https://www.ebi.ac.uk/gwas/ 
 
RegionAnnotator: https://github.com/ivankosmos/RegionAnnotator  
 
Generalized Summary-data-based Mendelian Randomization software: 
http://cnsgenomics.com/software/gsmr/ 
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Figure Legends 
Figure 1. SNP-based associations with intelligence in the GWAS meta-analysis of N=269,867 
independent individuals. (a) Manhattan plot showing the ─log10 transformed two-tailed P-
value of each SNP from the GWAS meta-analysis (of linear and logistic regression statistics) 
on the y-axis and base pair positions along the chromosomes on the x-axis. The dotted red 
line indicates Bonferroni-corrected genome-wide significance (P<5×10-8); the blue line the 
threshold for suggestive associations (P<1×10-5). Independent lead SNPs are indicated by a 
diamond. (b) Heritability enrichment of 28 functional annotation categories for SNPs in the 
meta-analysis, calculated with stratified LD score regression. Error bars show 95% confidence 
intervals around the enrichment estimate. The dashed horizontal line indicates no 
enrichment of the annotation category. Red dots indicate significant Bonferroni-corrected 
two-tailed P-values and beige dots indicate suggestive (P<.05) values. UTR=untranslated 
region; TSS=transcription start site; CTCF=CCCTC-binding factor; DHS=DNaseI Hypersensitive 
Site; TFBS=transcription factor binding site; DGF=DNaseI digital genomic footprint. (c) 
Distribution of functional consequences of SNPs in genomic risk loci in the meta-analysis. (d) 
Distribution of RegulomeDB score for SNPs in genomic risk loci, with a low score indicating a 
higher likelihood of having a regulatory function (Online methods). (e) The minimum 
chromatin state across 127 tissue and cell types for SNPs in genomic risk loci, with lower states 
indicating higher accessibility and states 1-7 referring to open chromatin states (Online 
Methods).  
 
Figure 2. Cross-locus interactions for genomic regions associated with intelligence in 
269,867 independent individuals. Circos plots showing genes on chromosomes 2 (a), 5 (b), 6 
(c), 9 (d), and 22 (e) that were linked to genomic risk loci in the GWAS meta-analysis (blue 
regions) by eQTL mapping (green lines connecting an eQTL SNP to its associated gene), and/or 
chromatin interactions (orange lines connecting two interacting regions) and showed 
evidence of interaction across two independent genomic risk loci. Genes implicated by eQTL 
are in green, by chromatin interactions in orange, and by both eQTL and chromatin 
interactions mapping in red. The outer layer shows a Manhattan plot containing the ─log10 
transformed two-tailed P-value of each SNP from the GWAS meta-analysis (of linear and 
logistic regression statistics), with genome-wide significant SNPs colored according to linkage 
disequilibrium patterns with the lead SNP. Circos plots for all chromosomes are provided in 
Supplementary Fig. 8.  
 
Figure 3. Implicated genes, pathways, and tissue- and cell- expression profiles for 
intelligence in 269,867 independent individuals. (a) Manhattan plot of the genome-wide 
gene-based association analysis (GWGAS). The y-axis shows the ─log10 transformed two-
tailed P-value of each gene from a linear model, and the chromosomal position on the x-axis. 
The red dotted line indicates the Bonferroni-corrected threshold for genome-wide 
significance of the gene-based test (P<2.76×10-6; 0.05/18,128 genes), and the blue line 
indicates the suggestive threshold (P<2.76×10-5; 0.5/18,128 genes) (b) Venn diagram showing 
overlap of genes implicated by positional mapping, eQTL mapping, chromatin interaction 
mapping, and GWGAS. (c) Gene expression profiles of associated genes in 53 tissue types. The 
y-axis shows the ─log10 transformed two-tailed P-value of association of GWGAS test 
statistics with tissue-specific gene expression levels in a linear model. Expression data were 
extracted from the Genotype-Tissue Expression (GTEx) database. Expression values (RPKM) 
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were log2 transformed with pseudocount 1 after winsorization at 50 and averaged per tissue. 
The dotted blue line indicates the Bonferroni-corrected significance threshold (P=0.05/7,323 
gene-sets=6.83×10-6). (d) Single-cell gene-expression analysis of genes related to intelligence 
in 24 cell-types. The x-axis shows the ─log10 transformed two-tailed P-value of association of 
GWGAS test statistics with cell-specific gene expression levels in a linear model.  The dotted 
blue line indicates the Bonferroni-corrected significance threshold (P=0.05/7,323 gene-
sets=6.83×10-6). 
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Tables 
 
Table 1. Overview of cohorts included in a GWAS meta-analysis of general intelligence. 
 
Cohort N Age Phenotype 
1. UKB 195,653 39-72 Verbal and mathematical reasoning 
2. COGENT 35,289 8-96 One or more neuropsychological tests from three or more 
domains of cognitive performance 
3. RS  6,182 45-98 Letter-digit substitution, Stroop, verbal fluency, delayed 
recall 
4. GENR 1,929 5-9 SON-R (spatial visualization and abstract reasoning subsets) 
5. STR 3,215 18 Logical, verbal, spatial, and technical ability subtests 
6. S4S 2,818 17-18 SAT test scores 
7. HiQ / HRS 9,410 * High IQ cases / unselected population controls 
8. TEDS 3,414 12 WISC-III verbal and nonverbal reasoning; Raven's 
progressive matrices 
9a. DTR - MADT 737 55-80 Verbal fluency, digit span, immediate and delayed recall 
tests 
9b. DTR - LSADT 253 73-94 Verbal fluency, digit span, immediate and delayed recall 
tests 
10. IMAGEN 1,343 14 WISC-IV, CANTAB factor score 
11a. BLTS - 
Children 
530 12-13 VSRT-C factor score 
11b. BLTS - 
Adolescents 
2,598 15-30 MAB-II IQ score 
12. NESCOG 252 18-79 WAIS IQ score 
13. GfG 5,084 15-91 ICAR verbal reasoning test 
14a. STSA - 
SATSA+GENDER 
703 50-94 Verbal, spatial, episodic memory, and processing speed 
tests 
14b. STSA - 
HARMONY 
448 65-96 Verbal, spatial, episodic memory, and processing speed 
tests 
* HiQ/HRS sample used a case-control design rather than a cognitive test score ascertained 
at a specific age; see Online Methods and Supplementary information 1.1.  
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Online Methods 
Study Cohorts 
The meta-analysis included new and previously reported GWAS summary statistics from 14 
cohorts: UK Biobank (UKB), Cognitive Genomics Consortium (COGENT), Rotterdam Study (RS), 
Generation R Study (GENR), Swedish Twin Registry (STR), Spit for Science (S4S), High-
IQ/Health and Retirement Study (HiQ/HRS), Twins Early Development Study (TEDS), Danish 
Twin Registry (DTR), IMAGEN, Brisbane Longitudinal Twin Study (BLTS), Netherlands Study of 
Cognition, Environment and Genes (NESCOG), Genes for Good (GfG), and the Swedish Twin 
Studies of Aging (STSA). All samples were obtained from epidemiological cohorts ascertained 
for research on a variety of physical and psychological outcomes. Participants ranged from 
children to older adults, with older samples being screened for cognitive decline to exclude 
the possibility of dementia affecting performance on cognitive tests.  
Different measures of intelligence were assessed in each cohort but were all operationalized 
to index a common latent g factor underlying multiple dimensions of cognitive functioning. 
With the exception of HiQ/HRS, all cohorts extracted a single sum score, mean score, or factor 
score from a multidimensional set of cognitive performance tests and used this normally-
distributed score as the phenotype in a covariate-adjusted (e.g. age, sex, ancestry principal 
components) GWAS using linear regression methods. For HiQ/HRS, a logistic regression GWAS 
was run with “case” status reflecting whether participants were drawn from an extreme-
sampled population of very high intelligence (i.e. at the upper ~0.03% of the tail of the normal 
distribution) versus an epidemiological sample of unselected population “controls”. Detailed 
descriptions of the samples, measures, genotyping, quality control, and analysis procedures 
for each cohort are provided in the Supplementary Note (Supplementary Information 1.1-
1.2), Supplementary Table 1, and in the Life Sciences Reporting Summary.  
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Meta-analysis 
Stringent quality control measures were applied to the summary statistics for each GWAS 
cohort before combining. All files were checked for data integrity and accuracy. SNPs were 
filtered from further analysis if they met any of the following criteria: imputation quality 
(INFO/R2) score < 0.6, Hardy-Weinberg equilibrium (HWE) P < 5×10-6, study-specific minor 
allele frequency (MAF) corresponding to a minor allele count (MAC) < 100, and mismatch of 
alleles or allele frequency difference greater than 20% from the Haplotype Reference 
Consortium (HRC) genome reference panel16. Some cohorts used more stringent criteria (see 
Supplementary Information 1.1). Indels and SNPs that were duplicated, multi-allelic, 
monomorphic, or ambiguous (A/T or C/G with a MAF >0.4) were also excluded. Visual 
inspection of the distribution of the summary statistics was completed, and Manhattan plots 
and QQ plots were created for the cleaned summary statistics from each cohort 
(Supplementary Figure 1).  
The SNP association P-values from the GWAS cohorts were meta-analyzed with METAL34 (see 
URLs) in two phases. First, we meta-analyzed all cohorts with quantitative phenotypes (all 
except HiQ/HRS) using a sample-size weighted scheme. In the second phase, we added the 
HiQ/HRS study results to the first phase results, weighting each set of summary statistics by 
their respective non-centrality parameter (NCP). This method improves power when using an 
extreme case sampling design such as HiQ35 and provides a comparable metric with which to 
combine information from different analytic designs while accounting for their differences in 
power/effective sample size. NCPs were estimated using the Genetic Power Calculator36, as 
described by Coleman et al.37. After combining all data, meta-analysis results were further 
filtered to exclude any variants with N < 50,000. We additionally included a random-effects 
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meta-analysis for each phase, as implemented in METAL, to evaluate potential heterogeneity 
in the SNP association statistics between cohorts. 
The X chromosome was treated separately in the meta-analysis because imputed genotypes 
were not available for the X chromosome in the largest cohort (UKB), and there was little 
overlap between the UKB called genotypes and imputed data from other cohorts (NSNPs < 
500). We therefore included only the called X chromosome variants in UKB for these analyses 
after performing X-specific quality control steps38.   
We conducted a series of meta-analyses on subsets of the full sample using the same methods 
as above. Age group-specific meta-analyses were run in the cohorts of children (age < 17; 
GENR, TEDS, IMAGEN, BLTS; N=9,814), young adults (age ~17-18; S4S, STR; N=6,033), adults 
(age > 18, primarily middle-aged or older: UKB, RS, DTR, NESCOG, STSA; N=204,228), and older 
adults (mean age > 60, RS, DTR, STSA; N=8,323), excluding studies whose samples overlapped 
child/young adult and adult groups (COGENT, HiQ/HRS, GfG; N=49,792). To create 
independent discovery samples for use in polygenic score validation, we also conducted 
meta-analyses with a “leave-one-out” strategy in which summary statistics from four 
validation datasets were, respectively, excluded from the meta-analysis (see Polygenic 
Scoring, below).  
 
Cohort Heritability and Genetic Correlation  
LD score regression17 was used to estimate genomic inflation and heritability of the 
intelligence phenotypes in each of the 14 cohorts using their post-quality control summary 
statistics, and to estimate the cross-cohort genetic correlations39. Pre-calculated LD scores 
from the 1000 Genomes European reference population were obtained online (see URLs). 
Genetic correlations were calculated on HapMap3 SNPs only. LD score regression was also 
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used on the age subgroup meta-analyses to estimate heritability and cross-age genetic 
correlations. 
 
Genomic Risk Loci Definition 
Independently associated loci from the meta-analysis were defined using FUMA24 (see URLs), 
an online platform for functional mapping of genetic variants. We first identified independent 
significant SNPs which had a Bonferroni-corrected genome-wide significant two-tailed P-
value (P<5×10-8) and represented signals that were independent from each other at r2<0.6. 
These SNPs were further represented by lead SNPs, which are a subset of the independent 
significant SNPs that are in approximate linkage equilibrium with each other at r2<0.1. We 
then defined associated genomic loci by merging any physically overlapping lead SNPs 
(linkage disequilibrium [LD] blocks <250kb apart). Borders of the associated genomic loci were 
defined by identifying all SNPs in LD (r2≧0.6) with one of the independent significant SNPs in 
the locus, and the region containing all of these candidate SNPs was considered to be a single 
independent genomic locus. All LD information was calculated from UK Biobank genotype 
data. 
 
Proxy-replication with Educational Attainment 
We conducted GWAS of educational attainment, an outcome with a high genetic correlation 
with intelligence5, in a non-overlapping European subset of the UKB sample (N=188,435) who 
did not complete the intelligence measure. Educational attainment was coded as maximum 
years of education completed, using the same methods as earlier analyses40 and GWAS was 
conducted using the same quality control and analytic procedures as described for the UKB 
intelligence phenotype (Supplementary Information 1.1.1). To test replication of the SNPs 
GWAS META-ANALYSIS OF INTELLIGENCE   24 
with this proxy phenotype, we performed a sign concordance test for all GWS SNPs from the 
meta-analysis using the two-tailed exact binomial test. For each independent genomic locus, 
we considered it to be evidence for replication if the lead SNP or another correlated SNP in 
the region was sign concordant with the corresponding SNP in the intelligence meta-analysis 
and had a two-tailed P-value of association with educational attainment smaller than 
0.05/242 independent tests=0.0002. 
 
Polygenic Scoring 
We calculated polygenic scores (PGS) based on the SNP effect sizes of the leave-one-out 
meta-analyses, from which four cohorts were (separately) excluded and reserved for score 
validation. These included a child (GENR), young adult (S4S), and adult sample (RS). We also 
included the UKB-wb sample to test for validation in a very large (N = 53,576) cohort with the 
greatest phenotypic similarity to the largest contributor to the meta-analysis statistics (UKB-
ts), in order to maximize potential predictive power. PGS were calculated on the genotype 
data using LDpred21, a Bayesian PGS method that utilizes a prior on effect size distribution to 
remodel the SNP effect size and account for LD, and PRSice20, a PLINK41-based program that 
automates optimization of the set of SNPs included in the PGS based on a high-resolution 
filtering of the GWAS P-value threshold. LDpred PGS were applied to the called, cleaned, 
genotyped variants in each of the validation cohorts with UK Biobank as the LD reference 
panel. PRSice PGS were calculated on hard-called imputed genotypes using P-value thresholds 
from 0.0 to 0.5 in steps of 0.001. The explained variance (ΔR2) was derived from a linear model 
in which the GWAS intelligence phenotype was regressed on each PGS while controlling for 
the same covariates as in each cohort-specific GWAS, compared to a linear model with GWAS 
covariates only. 
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Stratified Heritability 
We partitioned SNP heritability using stratified LD Score regression42 in three ways: 1) by 
functional annotation category, 2) by minor allele frequency (MAF) in six percentile bins, and 
3) by chromosome. Annotations for 28 binary categories of putative functional genomic 
characteristics (e.g. coding or regulatory regions) were obtained from the LD score website 
(see URLs). With this method, enrichment/depletion of heritability in each category is 
calculated as the proportion of heritability attributable to SNPs in the specified category 
divided by the proportion of total SNPs annotated to that category. The Bonferroni-corrected 
significance threshold was .05/56 annotations=.0009. 
 
Functional Annotation of SNPs 
Functional annotation of SNPs implicated in the meta-analysis was performed using FUMA24 
(see URLs). We selected all candidate SNPs in associated genomic loci having an r2≧0.6 with 
one of the independent significant SNPs (see above), a suggestive P-value (P<1e-5) and a 
MAF>0.0001 for annotations. Predicted functional consequences for these SNPs were 
obtained by matching SNPs’ chromosome, base-pair position, and reference and alternate 
alleles to databases containing known functional annotations, including ANNOVAR43 
categories, Combined Annotation Dependent Depletion (CADD) scores23, RegulomeDB44 
(RDB) scores, and chromatin states45,46. ANNOVAR categories identify the SNP’s genic position 
(e.g. intron, exon, intergenic) and associated function. CADD scores predict how deleterious 
the effect of a SNP is likely to be for a protein structure/function, with higher scores referring 
to higher deleteriousness. A CADD score above 12.37 is the threshold to be potentially 
pathogenic23. The RegulomeDB score is a categorical score based on information from 
GWAS META-ANALYSIS OF INTELLIGENCE   26 
expression quantitative trait loci (eQTLs) and chromatin marks, ranging from 1a to 7 with 
lower scores indicating an increased likelihood of having a regulatory function. Scores are as 
follows: 1a=eQTL + Transcription Factor (TF) binding + matched TF motif + matched DNase 
Footprint + DNase peak; 1b=eQTL + TF binding + any motif + DNase Footprint + DNase peak; 
1c=eQTL + TF binding + matched TF motif + DNase peak; 1d=eQTL + TF binding + any motif + 
DNase peak; 1e=eQTL + TF binding + matched TF motif; 1f=eQTL + TF binding / DNase peak; 
2a=TF binding + matched TF motif + matched DNase Footprint + DNase peak; 2b=TF binding 
+ any motif + DNase Footprint + DNase peak; 2c=TF binding + matched TF motif + DNase peak; 
3a=TF binding + any motif + DNase peak; 3b=TF binding + matched TF motif; 4=TF binding + 
DNase peak; 5=TF binding or DNase peak; 6=other; 7=Not available. The chromatin state 
represents the accessibility of genomic regions (every 200bp) with 15 categorical states 
predicted by a hidden Markov model based on 5 chromatin marks for 127 epigenomes in the 
Roadmap Epigenomics Project46. A lower state indicates higher accessibility, with states 1-7 
referring to open chromatin states. We annotated the minimum chromatin state across 
tissues to SNPs. The 15-core chromatin states as suggested by Roadmap are as follows: 
1=Active Transcription Start Site (TSS); 2=Flanking Active TSS; 3=Transcription at gene 5’ and 
3’; 4=Strong transcription; 5= Weak Transcription; 6=Genic enhancers; 7=Enhancers; 8=Zinc 
finger genes & repeats; 9=Heterochromatic; 10=Bivalent/Poised TSS; 11=Flanking 
Bivalent/Poised TSS/Enhancer; 12=Bivalent Enhancer; 13=Repressed PolyComb; 14=Weak 
Repressed PolyComb; 15=Quiescent/Low. Standardized SNP effect sizes were calculated for 
the most impactful SNPs by transforming the sample size-weighted meta-analysis Z score, as 
described by Zhu et al.47. 
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Gene-mapping 
Genome-wide significant loci obtained by the GWAS meta-analysis were mapped to genes in 
FUMA24 using three strategies: 
1. Positional mapping maps SNPs to genes based on physical distance (within a 10kb 
window) from known protein coding genes in the human reference assembly 
(GRCh37/hg19).  
2. eQTL mapping maps SNPs to genes with which they show a significant eQTL 
association (i.e. allelic variation at the SNP is associated with the expression level of 
that gene). eQTL mapping uses information from 45 tissue types in 3 data repositories 
(GTEx48, Blood eQTL browser49, BIOS QTL browser50), and is based on cis-eQTLs which 
can map SNPs to genes up to 1Mb apart. We used a false discovery rate (FDR) of 0.05 
to define significant eQTL associations. 
3. Chromatin interaction mapping was performed to map SNPs to genes when there is a 
three-dimensional DNA-DNA interaction between the SNP region and a gene region. 
Chromatin interaction mapping can involve long-range interactions as it does not have 
a distance boundary. FUMA currently contains Hi-C data of 14 tissue types from the 
study of Schmitt et al51. Since chromatin interactions are often defined in a certain 
resolution, such as 40kb, an interacting region can span multiple genes. If a SNPs is 
located in a region that interacts with a region containing multiple genes, it will be 
mapped to each of those genes. To further prioritize candidate genes, we selected 
only interaction-mapped genes in which one region involved in the interaction 
overlaps with a predicted enhancer region in any of the 111 tissue/cell types from the 
Roadmap Epigenomics Project46 and the other region is located in a gene promoter 
region (250bp up and 500bp downstream of the transcription start site and also 
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predicted by Roadmap to be a promoter region). This reduces the number of genes 
mapped but increases the likelihood that those identified will have a plausible 
biological function. We used a FDR of 1×10-5 to define significant interactions, based 
on previous recommendations51 modified to account for the differences in cell lines 
used here. 
 
Functional annotation of mapped genes 
Genes implicated by mapping of significant GWAS SNPs were further investigated using the 
GENE2FUNC procedure in FUMA24, which provides hypergeometric tests of enrichment of 
the list of mapped genes in 53 GTEx48 tissue-specific gene expression sets, 7,246 MSigDB 
gene-sets52, and 2,195 GWAS catalog gene-sets28. The Bonferroni-corrected significance 
threshold was 0.05/9,494 gene-sets=5.27×10-6. 
 
Gene-based analysis 
SNP-based P-values from the meta-analysis were used as input for the gene-based genome-
wide association analysis (GWGAS). 18,128 protein-coding genes (each containing at least 1 
GWAS SNP) from the NCBI 37.3 gene definitions were used as basis for GWGAS in MAGMA25 
(see URLs). The Bonferroni-corrected genome-wide significance threshold was .05/18,128 
genes=2.76×10-6.   
 
Gene-set analysis 
Results from the GWGAS analyses were used to test for association in three types of 
predefined gene-sets:  
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1. 7,246 curated gene-sets representing known biological and metabolic pathways were 
derived from 9 data resources, catalogued by and obtained from the MsigDB version 
5.229 (see URLs) 
2. gene expression values from 53 tissues obtained from GTEx48, log2 transformed with 
pseudocount 1 after winsorization at 50 and averaged per tissue   
3. cell-type specific gene expression in 24 types of brain cells, which were calculated 
following the method described in Skene et al.53 and Coleman et al.37 Briefly, brain 
cell-type expression data was drawn from single-cell RNA sequencing data from 
mouse brains. For each gene, the value for each cell-type was calculated by dividing 
the mean Unique Molecular Identifier (UMI) counts for the given cell type by the 
summed mean UMI counts across all cell types. Single-cell gene-sets were derived by 
grouping genes into 40 equal bins by specificity of expression.  
These gene-sets were tested for association with the GWGAS gene-based test statistics using 
MAGMA. We computed competitive P-values, which represent the test of association for a 
specific gene-set compared to other gene-sets. This method is more robust to Type I error 
than self-contained tests that only test for association of a gene-set against the null 
hypothesis of no association25. The Bonferroni-corrected significance threshold was 
0.05/7,323 gene-sets=6.83×10-6. Conditional analyses were performed as a follow-up using 
MAGMA to test whether each significant association observed was independent of all others. 
The association between each gene-set was tested conditional on the most strongly 
associated set, and then - if any substantial (p<.05/number of gene-sets) associations 
remained - by conditioning on the first and second most strongly associated set, and so on 
until no associations remained. Gene-sets that retained their association after correcting for 
other sets were considered to be independent signals. We note that this is not a test of 
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association per se, but rather a strategy to identify, among gene-sets with known significant 
associations whose defining genes may overlap, which set(s) are responsible for driving the 
observed association. 
 
Cross-Trait Genetic Correlation 
Genetic correlations (rg) between intelligence and 38 phenotypes were computed using LD 
score regression39, as described above, based on GWAS summary statistics obtained from 
publicly available databases (see URLs; Supplementary Table 18). The Bonferroni-corrected 
significance threshold was 0.05/38 traits=1.32×10-3. 
 
GWAS catalog lookup 
We used FUMA to identify SNPs with previously reported (P < 5×10-5) phenotypic associations 
in published GWAS listed in the NHGRI-EBI catalog28 which overlapped with the genomic risk 
loci identified in the meta-analysis. As an additional relevant phenotype of interest, we 
examined whether the genes associated with intelligence in this study (by FUMA mapping or 
GWGAS) were overrepresented in a set of 1,518 genes linked to intellectual disability and/or 
developmental delay, as compiled by RegionAnnotater (see URLs). Many of these have been 
identified by non-GWAS sources and are not represented in the NHGRI catalog. We tested for 
enrichment using a hypergeometric test with a background set of 19,283 genomic protein-
coding genes, as in FUMA. Manual lookups were also performed to identify overlapping 
loci/genes with known previous GWAS of intelligence. 
 
Mendelian Randomization 
To infer credible causal associations between intelligence and traits that are genetically 
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correlated with intelligence, we performed Generalized Summary-data based Mendelian 
Randomization29 (GSMR; see URLs). This method utilizes summary-level data to test for causal 
associations between a putative risk factor (exposure) and an outcome by using independent 
genome-wide significant SNPs as instrumental variables. HEIDI-outlier detection was used to 
filter genetic instruments that show clear pleiotropic effects on both the exposure phenotype 
and the outcome phenotype. We used a threshold p-value of 0.01 for the outlier detection 
analysis in HEIDI which removes 1% of SNPs by chance if there is no pleiotropic effect. To test 
for a potential causal effect of intelligence on various outcomes, we selected traits in non-
overlapping samples that showed significant genetic correlations (rg) with intelligence. We 
tested for bi-directional causation by repeating the analyses while switching the role of each 
correlated phenotype as an exposure and intelligence as the outcome. For each trait, we 
selected independent (r2=<0.1), GWS lead SNPs as instrumental variables in the analyses. For 
traits with less than 10 GWS lead SNPs (i.e. the minimum number of SNPs on which GSMR can 
perform a reliable analysis), the GWS threshold was lowered to 1×10-5, allowing a sufficient 
number of SNPs to conduct the reverse GSMR analysis for former smoker status, autism, and 
intracranial volume.  
The method estimates a putative causal effect of the exposure on the outcome (bxy) as a 
function of the relationship between the SNPs’ effects on the exposure (bzx) and the SNPs’ 
effects on the outcome (bzy), given the assumption that the effect of non-pleiotropic SNPs on 
an exposure (x) should be related to their effect on the outcome (y) in an independent sample 
only via mediation through the phenotypic causal pathway (bxy). The estimated causal effect 
coefficients (bxy) are approximately equal to the natural log odds ratio (OR) for a case-control 
trait29. An OR of 2 can be interpreted as a doubled risk compared to the population prevalence 
of a binary trait for every SD increase in the exposure trait. For quantitative traits the bxy can 
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be interpreted as a one standard deviation increase explained in the outcome trait for every 
SD increase in the exposure trait. This method can help differentiate the likely causal direction 
of association between two traits but cannot make any statement about the intermediate 
mechanisms involved in any potential causal process.  
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Data Availability Statement 
Summary statistics will be available for download upon publication from https://ctg.cncr.nl.  
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